These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12477167)

  • 21. Mutations in the peripheral myelin protein zero and connexin32 genes detected by non-isotopic RNase cleavage assay and their phenotypes in Japanese patients with Charcot-Marie-Tooth disease.
    Yoshihara T; Yamamoto M; Doyu M; Mis KI; Hattori N; Hasegawa Y; Mokuno K; Mitsuma T; Sobue G
    Hum Mutat; 2000 Aug; 16(2):177-8. PubMed ID: 10923043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models.
    Perez-Olle R; Jones ST; Liem RK
    Hum Mol Genet; 2004 Oct; 13(19):2207-20. PubMed ID: 15282209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to assess the pathogenicity of mutations in Charcot-Marie-Tooth disease and other diseases?
    Kochański A
    J Appl Genet; 2006; 47(3):255-60. PubMed ID: 16877806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1.
    Zhai J; Lin H; Julien JP; Schlaepfer WW
    Hum Mol Genet; 2007 Dec; 16(24):3103-16. PubMed ID: 17881652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review and analysis of the clinical literature on Charcot-Marie-Tooth disease caused by mutations in neurofilament protein L.
    Stone EJ; Kolb SJ; Brown A
    Cytoskeleton (Hoboken); 2021 Mar; 78(3):97-110. PubMed ID: 33993654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.
    Berciano J; Peeters K; García A; López-Alburquerque T; Gallardo E; Hernández-Fabián A; Pelayo-Negro AL; De Vriendt E; Infante J; Jordanova A
    J Neurol; 2016 Feb; 263(2):361-369. PubMed ID: 26645395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E.
    Fabrizi GM; Cavallaro T; Angiari C; Bertolasi L; Cabrini I; Ferrarini M; Rizzuto N
    Neurology; 2004 Apr; 62(8):1429-31. PubMed ID: 15111691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family.
    Georgiou DM; Zidar J; Korosec M; Middleton LT; Kyriakides T; Christodoulou K
    Neurogenetics; 2002 Oct; 4(2):93-6. PubMed ID: 12481988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and genetic characterization of NEFL-related neuropathy in Taiwan.
    Chao HC; Hsiao CT; Lai KL; Tsai YS; Lin KP; Liao YC; Lee YC
    J Formos Med Assoc; 2023 Feb; 122(2):132-138. PubMed ID: 36031490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and mutational spectrum of Charcot-Marie-Tooth disease type 2Z caused by MORC2 variants in Japan.
    Ando M; Okamoto Y; Yoshimura A; Yuan JH; Hiramatsu Y; Higuchi Y; Hashiguchi A; Mitsui J; Ishiura H; Fukumura S; Matsushima M; Ochi N; Tsugawa J; Morishita S; Tsuji S; Takashima H
    Eur J Neurol; 2017 Oct; 24(10):1274-1282. PubMed ID: 28771897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axonal Charcot-Marie-Tooth disease and the neurofilament light gene (NF-L).
    Lupski JR
    Am J Hum Genet; 2000 Jul; 67(1):8-10. PubMed ID: 10848490
    [No Abstract]   [Full Text] [Related]  

  • 32. Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants.
    Sasaki T; Gotow T; Shiozaki M; Sakaue F; Saito T; Julien JP; Uchiyama Y; Hisanaga S
    Hum Mol Genet; 2006 Mar; 15(6):943-52. PubMed ID: 16452125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot-Marie- Tooth disease type 2E.
    Elbracht M; Senderek J; Schara U; Nolte K; Klopstock T; Roos A; Reimann J; Zerres K; Weis J; Rudnik-Schöneborn S
    Clin Neuropathol; 2014; 33(5):335-43. PubMed ID: 24887401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel pathogenic variant of NEFL responsible for deafness associated with peripheral neuropathy discovered through next-generation sequencing and review of the literature.
    Lerat J; Magdelaine C; Beauvais-Dzugan H; Espil C; Ghorab K; Latour P; Derouault P; Sturtz F; Lia AS
    J Peripher Nerv Syst; 2019 Mar; 24(1):139-144. PubMed ID: 30734407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Genetic and Biochemical Insights into the Spectrum of NEFL-Associated Phenotypes.
    Della Marina A; Hentschel A; Czech A; Schara-Schmidt U; Preusse C; Laner A; Abicht A; Ruck T; Weis J; Choueiri C; Lochmüller H; Kölbel H; Roos A
    J Neuromuscul Dis; 2024; 11(3):625-645. PubMed ID: 38578900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel out-of-frame mutation in the neurofilament light chain gene (NEFL) does not result in Charcot-Marie-Tooth disease type 2E.
    Andrigo C; Boito C; Prandini P; Mostacciuolo ML; Siciliano G; Angelini C; Pegoraro E
    Neurogenetics; 2005 Feb; 6(1):49-50. PubMed ID: 15654615
    [No Abstract]   [Full Text] [Related]  

  • 37. Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth disease.
    Choi BO; Koo SK; Park MH; Rhee H; Yang SJ; Choi KG; Jung SC; Kim HS; Hyun YS; Nakhro K; Lee HJ; Woo HM; Chung KW
    Hum Mutat; 2012 Nov; 33(11):1610-5. PubMed ID: 22730194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation.
    Perez-Olle R; Leung CL; Liem RK
    J Cell Sci; 2002 Dec; 115(Pt 24):4937-46. PubMed ID: 12432080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport.
    Pérez-Ollé R; López-Toledano MA; Goryunov D; Cabrera-Poch N; Stefanis L; Brown K; Liem RK
    J Neurochem; 2005 May; 93(4):861-74. PubMed ID: 15857389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and functional characterization of two missense mutations in NDRG1 associated with Charcot-Marie-Tooth disease type 4D.
    Li LX; Liu GL; Liu ZJ; Lu C; Wu ZY
    Hum Mutat; 2017 Nov; 38(11):1569-1578. PubMed ID: 28776325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.